talactoferrin alfa has been researched along with Bacteremia in 1 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sherman, MP | 1 |
Adamkin, DH | 1 |
Niklas, V | 1 |
Radmacher, P | 1 |
Sherman, J | 1 |
Wertheimer, F | 1 |
Petrak, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants[NCT00854633] | Phase 1/Phase 2 | 120 participants (Anticipated) | Interventional | 2009-06-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for talactoferrin alfa and Bacteremia
Article | Year |
---|---|
Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants.
Topics: Administration, Oral; Bacteremia; Cross Infection; Double-Blind Method; Enterocolitis, Necrotizing; | 2016 |